Samba Biologics Inc.
South Hero, VT
- UEI
- FHEJW958JKD8
- CAGE
- 6VJH6
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 146 W Shore Rd, South Hero, VT 05486, USA
- Website
- sambabiologics.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Vasaplex-based biologics for treatment of reperfusion injury after myocardial infarction | National Heart Lung and Blood Institute (NIH) | $996,542 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Transira Therapeutics LLC | Getzville, NY | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Led Radiofluidics Corp | Chapel Hill, NC | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
SBA capabilities narrative
We design and develop biologic drugs and cell-based therapeutics.
Quick answers
Is Samba Biologics Inc. registered in SAM.gov?
Yes. Samba Biologics Inc.'s SAM.gov registration is active through January 21, 2027.
What is Samba Biologics Inc.'s most recent federal award?
Samba Biologics Inc.'s most recent federal grant award is Vasaplex-based biologics for treatment of reperfusion injury after myocardial infarction (R41HL162161), from National Heart Lung and Blood Institute (NIH), on March 11, 2022.
On GovTribe
See Samba Biologics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors